130 related articles for article (PubMed ID: 10091703)
21. Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis rat.
Uknis AB; DeLa Cadena RA; Janardham R; Sartor RB; Whalley ET; Colman RW
Inflamm Res; 2001 Mar; 50(3):149-55. PubMed ID: 11339503
[TBL] [Abstract][Full Text] [Related]
22. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
[TBL] [Abstract][Full Text] [Related]
23. Interaction of linear and cyclic peptide antagonists at the human B(2) kinin receptor.
Cucchi P; Meini S; Quartara L; Giolitti A; Zappitelli S; Rotondaro L; Maggi CA
Peptides; 2002 Aug; 23(8):1457-63. PubMed ID: 12182947
[TBL] [Abstract][Full Text] [Related]
24. Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum.
Kam YL; Ro JY; Kim HJ; Choo HY
Eur J Pharmacol; 2005 Oct; 523(1-3):143-50. PubMed ID: 16226247
[TBL] [Abstract][Full Text] [Related]
25. Hoe 140 and pseudo-irreversible antagonism in the rat vas deferens in vitro.
Asghar AU; Wheeldon A; Coleman RA; Bountra C; McQueen DS
Eur J Pharmacol; 2000 Jun; 398(1):131-8. PubMed ID: 10856457
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.
Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A
Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537
[TBL] [Abstract][Full Text] [Related]
27. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
28. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
[TBL] [Abstract][Full Text] [Related]
29. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.
Miskolzie M; Gera L; Stewart JM; Kotovych G
J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and pharmacological evaluation of dimer derivatives of the bradykinin receptor antagonist HOE-140.
Daffix I; Amblard M; Bergé G; Dodey P; Pruneau D; Paquet JL; Fouchet C; Franck RM; Defrêne E; Luccarini JM; Bélichard P; Martinez J
J Pept Res; 1998 Jul; 52(1):1-14. PubMed ID: 9716245
[TBL] [Abstract][Full Text] [Related]
31. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
32. Potent, long-acting bradykinin antagonists for a wide range of applications.
Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154
[TBL] [Abstract][Full Text] [Related]
33. Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different species.
Félétou M; Germain M; Thurieau C; Fauchère JL; Canet E
Br J Pharmacol; 1994 Jun; 112(2):683-9. PubMed ID: 8075888
[TBL] [Abstract][Full Text] [Related]
34. Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications.
Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
Immunopharmacology; 1997 Jun; 36(2-3):167-72. PubMed ID: 9228542
[TBL] [Abstract][Full Text] [Related]
35. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
Field JL; Butt SK; Morton IK; Hall JM
Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
[TBL] [Abstract][Full Text] [Related]
36. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.
Cloutier F; Ongali B; Campos MM; Thibault G; Neugebauer W; Couture R
Br J Pharmacol; 2004 May; 142(2):285-96. PubMed ID: 15066903
[TBL] [Abstract][Full Text] [Related]
37. Antagonists for kinin B1 and B2 receptors in the mouse.
Nsa Allogho S; Gobeil F; Pheng LH; Nguyen-Le XK; Neugebauer W; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):558-62. PubMed ID: 9276128
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design of six novel classes of nonpeptide antagonists of the bradykinin B2 receptor.
Artis DR; Brotherton-Pleiss C; Pease JH; Lin CJ; Ferla SW; Newman SR; Bhakta S; Ostrelich H; Jarnagin K
Bioorg Med Chem Lett; 2000 Nov; 10(21):2421-5. PubMed ID: 11078192
[TBL] [Abstract][Full Text] [Related]
39. Effect of chronic bradykinin B2 receptor blockade on blood pressure of conscious Dahl salt-resistant rats.
Mukai H; Fitzgibbon WR; Ploth DW; Margolius HS
Br J Pharmacol; 1998 May; 124(1):197-205. PubMed ID: 9630360
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors.
Rizzi A; Rizzi C; Amadesi S; Calo' G; Varani K; Inamura N; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):361-7. PubMed ID: 10551272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
